Literature DB >> 28527918

Cytochrome P450 eicosanoids in cerebrovascular function and disease.

Catherine M Davis1, Xuehong Liu2, Nabil J Alkayed3.   

Abstract

Cytochrome P450 eicosanoids play important roles in brain function and disease through their complementary actions on cell-cell communications within the neurovascular unit (NVU) and mechanisms of brain injury. Epoxy- and hydroxyeicosanoids, respectively formed by cytochrome P450 epoxygenases and ω-hydroxylases, play opposing roles in cerebrovascular function and in pathological processes underlying neural injury, including ischemia, neuroinflammation and oxidative injury. P450 eicosanoids also contribute to cerebrovascular disease risk factors, including hypertension and diabetes. We summarize studies investigating the roles P450 eicosanoids in cerebrovascular physiology and disease to highlight the existing balance between these important lipid signaling molecules, as well as their roles in maintaining neurovascular homeostasis and in acute and chronic neurovascular and neurodegenerative disorders.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebrovascular; Cytochrome P450; EETs; HETEs; Neurovascular unit; sEH

Mesh:

Substances:

Year:  2017        PMID: 28527918      PMCID: PMC5651205          DOI: 10.1016/j.pharmthera.2017.05.004

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  199 in total

1.  Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels.

Authors:  Xiang Fang; Neal L Weintraub; Ryan B McCaw; Shanming Hu; Shawn D Harmon; James B Rice; Bruce D Hammock; Arthur A Spector
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07-29       Impact factor: 4.733

2.  Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects.

Authors:  Dawn Chen; Randall Whitcomb; Euan MacIntyre; Vinh Tran; Zung N Do; James Sabry; Dinesh V Patel; Sampath K Anandan; Richard Gless; Heather K Webb
Journal:  J Clin Pharmacol       Date:  2011-03-21       Impact factor: 3.126

Review 3.  Cytochrome P450 eicosanoids and cerebral vascular function.

Authors:  John D Imig; Alexis N Simpkins; Marija Renic; David R Harder
Journal:  Expert Rev Mol Med       Date:  2011-03-01       Impact factor: 5.600

4.  Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes.

Authors:  N J Alkayed; J Narayanan; D Gebremedhin; M Medhora; R J Roman; D R Harder
Journal:  Stroke       Date:  1996-05       Impact factor: 7.914

5.  Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia.

Authors:  Samuel M Poloyac; Yuqing Zhang; Robert R Bies; Patrick M Kochanek; Steven H Graham
Journal:  J Cereb Blood Flow Metab       Date:  2006-03-29       Impact factor: 6.200

6.  Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice.

Authors:  Ayala Luria; Steven M Weldon; Alisa K Kabcenell; Richard H Ingraham; Damian Matera; Huiping Jiang; Rajan Gill; Christophe Morisseau; John W Newman; Bruce D Hammock
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

7.  Time course of vasospasm in man.

Authors:  B Weir; M Grace; J Hansen; C Rothberg
Journal:  J Neurosurg       Date:  1978-02       Impact factor: 5.115

8.  Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.

Authors:  W B Campbell; D Gebremedhin; P F Pratt; D R Harder
Journal:  Circ Res       Date:  1996-03       Impact factor: 17.367

9.  Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats.

Authors:  Yu Tanaka; Tomohiro Omura; Misako Fukasawa; Nobuko Horiuchi; Noriyuki Miyata; Toshiya Minagawa; Shigeru Yoshida; Shiro Nakaike
Journal:  Neurosci Res       Date:  2007-09-06       Impact factor: 3.304

10.  Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension.

Authors:  Harpreet Singh; Jennifer Cheng; Huan Deng; Rowena Kemp; Tsuneo Ishizuka; Alberto Nasjletti; Michal Laniado Schwartzman
Journal:  Hypertension       Date:  2007-06-04       Impact factor: 10.190

View more
  18 in total

Review 1.  Role of epoxy-fatty acids and epoxide hydrolases in the pathology of neuro-inflammation.

Authors:  Sean D Kodani; Christophe Morisseau
Journal:  Biochimie       Date:  2019-02-01       Impact factor: 4.079

2.  The arachidonic acid monooxygenase: from biochemical curiosity to physiological/pathophysiological significance.

Authors:  Jorge H Capdevila; John R Falck
Journal:  J Lipid Res       Date:  2018-08-28       Impact factor: 5.922

Review 3.  Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders.

Authors:  Sydney Zarriello; Julian P Tuazon; Sydney Corey; Samantha Schimmel; Mira Rajani; Anna Gorsky; Diego Incontri; Bruce D Hammock; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2018-11-14       Impact factor: 11.685

4.  Soluble Epoxide Hydrolase-Derived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive Impairment.

Authors:  Di Yu; Marie Hennebelle; Demetrios J Sahlas; Joel Ramirez; Fuqiang Gao; Mario Masellis; Hugo Cogo-Moreira; Richard H Swartz; Nathan Herrmann; Pak Cheung Chan; Jacqueline A Pettersen; Donald T Stuss; Sandra E Black; Ameer Y Taha; Walter Swardfager
Journal:  Transl Stroke Res       Date:  2018-11-15       Impact factor: 6.829

5.  Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis.

Authors:  Yi-Min Kuo; Pei-Chien Hsu; Chia-Chi Hung; Ya-Yu Hu; Yu-Jie Huang; Yu-Ling Gan; Chun-Hua Lin; Feng-Shiun Shie; Wen-Kuei Chang; Lung-Sen Kao; Mei-Yung Tsou; Yi-Hsuan Lee
Journal:  Mol Neurobiol       Date:  2019-07-01       Impact factor: 5.590

6.  A single meal has the potential to alter brain oxylipin content.

Authors:  J E Norman; H H Aung; Y Otoki; Z Zhang; A Y Taha; J C Rutledge
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2020-01-30       Impact factor: 4.006

7.  20-HETE synthesis inhibition promotes cerebral protection after intracerebral hemorrhage without inhibiting angiogenesis.

Authors:  Xiaoning Han; Xiaochun Zhao; Xi Lan; Qian Li; Yufeng Gao; Xi Liu; Jieru Wan; Zengjin Yang; Xuemei Chen; Weidong Zang; Austin M Guo; John R Falck; Raymond C Koehler; Jian Wang
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-27       Impact factor: 6.200

Review 8.  All for one, though not one for all: team players in normal tissue radiobiology.

Authors:  Marjan Boerma; Catherine M Davis; Isabel L Jackson; Dörthe Schaue; Jacqueline P Williams
Journal:  Int J Radiat Biol       Date:  2021-07-01       Impact factor: 2.694

9.  Role of endothelium-pericyte signaling in capillary blood flow response to neuronal activity.

Authors:  Wenri Zhang; Catherine M Davis; Douglas M Zeppenfeld; Kirsti Golgotiu; Marie X Wang; Mariya Haveliwala; Daniel Hong; Yuandong Li; Ruikang K Wang; Jeffrey J Iliff; Nabil J Alkayed
Journal:  J Cereb Blood Flow Metab       Date:  2021-04-14       Impact factor: 6.200

10.  A COX-2/sEH dual inhibitor PTUPB ameliorates cecal ligation and puncture-induced sepsis in mice via anti-inflammation and anti-oxidative stress.

Authors:  Yan-Feng Zhang; Chen-Chen Sun; Jia-Xi Duan; Hui-Hui Yang; Chen-Yu Zhang; Jian-Bing Xiong; Wen-Jing Zhong; Cheng Zu; Xin-Xin Guan; Hui-Ling Jiang; Bruce D Hammock; Sung Hee Hwang; Yong Zhou; Cha-Xiang Guan
Journal:  Biomed Pharmacother       Date:  2020-02-27       Impact factor: 6.529

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.